Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Journal of Medical Virology|January 16, 2025
Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection ProtocolHoong Kai Chua, Ananya Singh, Yuqian Wang, et al.Emerging Microbes & Infections|June 13, 2020
Serological differentiation between COVID-19 and SARS infectionsWan Ni Chia, Chee Wah Tan, Randy Foo, et al.Clinical & Translational Immunology|August 4, 2020
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infectionPei Hua Lee, Woo Chiao Tay, Stephanie Sutjipto, et al.Nature Biotechnology|July 25, 2020
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interactionChee Wah Tan, Wan Ni Chia, Xijian Qin, et al.Vaccines|April 23, 2025
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody ResponsesWeiyi Tang, Zi Wei Chang, Yun Shan Goh, et al.Plos Neglected Tropical Diseases|January 9, 2026
Proceedings of the inaugural symposium on dengue human challenge studies "Challenging the norm: Accelerating dengue countermeasures through human studies"Shirin Kalimuddin, Adam T Waickman, Panisadee Avirutnan, et al.Microbiology Spectrum|September 7, 2022
Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 VariantsHoi Lok Cheng, Sing Mei Lim, Huan Jia, et al.BMC Medicine|August 12, 2025
Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation studyKeisuke Ejima, Yuqian Wang, Akira Endo, et al.Trials|June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 1, 2024
COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infectionAniza P Mahyuddin, Hannah L F Swa, Ruifen Weng, et al.Pageof 7